LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research income statement 1986–2027

26.13B USD over the last twelve months, and 23.23B USD in fiscal year 2026.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
27 Sept 2026
FY2026
28 Jun 2026
FY2025
29 Jun 2025
FY2024
30 Jun 2024
FY2023
25 Jun 2023
FY2022
26 Jun 2022
FY2021
27 Jun 2021
FY2020
28 Jun 2020
FY2019
30 Jun 2019
FY2018
30 Jun 2018
FY2017
30 Jun 2017
Revenue
26.13B23.23B18.44B14.91B17.43B17.23B14.63B10.04B9.65B11.08B8.01B
Revenue growth
+33.36%+26.02%+23.68%-14.47%+1.16%+17.78%+45.61%+4.05%-12.85%+38.23%+36.15%
Cost of revenue
12.79B11.51B9.46B7.85B9.65B9.36B7.82B5.44B5.30B5.91B4.41B
Gross profit
13.34B11.73B8.98B7.05B7.78B7.87B6.81B4.61B4.36B5.17B3.60B
Gross margin
51.05%50.47%48.71%47.32%44.63%45.69%46.53%45.88%45.15%46.63%44.97%
Research and development
2.47B2.38B2.10B1.90B1.73B1.60B1.49B1.25B1.19B1.19B1.03B
Selling, general and administrative
1.22B1.15B981.70M868.25M832.75M885.74M829.88M682.48M702.41M762.22M667.49M
Operating expenses
3.68B3.53B3.08B2.79B2.60B2.49B2.32B1.93B1.89B1.95B1.70B
9.65B8.20B5.90B4.26B5.17B5.38B4.48B2.67B2.46B3.21B1.90B
Operating income growth
+49.31%+38.96%+38.39%-17.60%-3.85%+20.08%+67.63%+8.48%-23.30%+68.93%+77.07%
Operating margin
36.95%35.29%32.01%28.61%29.70%31.24%30.64%26.62%25.53%29.01%23.74%
Interest income
——231.33M251.94M138.98M15.21M19.69M85.43M98.77M85.81M57.86M
Interest expense
——178.20M185.24M186.46M184.76M208.60M177.44M117.26M97.39M117.73M
Other non-operating income
61.10M62.68M57.16M96.31M-65.65M-188.71M-111.22M-98.82M-18.16M-61.51M-90.46M
Pretax income
9.72B8.26B5.96B4.36B5.11B5.19B4.37B2.57B2.45B3.15B1.81B
Income tax
1.27B997.08M599.91M532.45M598.28M587.83M462.35M323.23M255.14M771.11M113.91M
Effective tax rate
13.03%12.07%10.07%12.21%11.71%11.32%10.58%12.55%10.43%24.47%6.29%
8.45B7.27B5.36B3.83B4.51B4.61B3.91B2.25B2.19B2.38B1.70B
Net income growth
+45.43%+35.59%+39.98%-15.14%-2.05%+17.83%+73.57%+2.75%-7.95%+40.22%+85.74%
Net margin
32.34%31.27%29.06%25.68%25.89%26.73%26.72%22.42%22.70%21.49%21.19%
Basic shares
1.25B1.26B1.29B1.31B1.35B1.40B1.44B1.45B1.52B1.81B1.62B
Diluted shares
1.26B1.26B1.29B1.32B1.36B1.41B1.45B1.49B1.60B1.81B1.84B
Change in diluted shares
-1.68%-2.25%-2.26%-2.83%-3.41%-3.23%-2.53%-6.77%-11.54%-1.63%+4.92%
EPS (basic)
6.755.794.172.913.333.292.721.561.441.471.05
EPS (diluted)
6.715.764.152.903.323.272.691.511.371.320.92
EPS growth
+47.80%+38.80%+43.10%-12.65%+1.53%+21.56%+78.15%+10.22%+3.79%+43.48%+76.92%
Dividends per share
1.111.040.920.800.690.600.520.460.440.260.17
Dividend growth
+16.84%+13.04%+15.00%+15.94%+15.00%+15.38%+13.04%+4.55%+72.55%+54.55%+37.50%
EBITDA
10.18B8.70B6.34B4.91B5.64B5.71B4.89B3.02B2.87B3.58B2.24B
EBITDA margin
38.95%37.46%34.41%32.91%32.35%33.15%33.41%30.07%29.76%32.28%27.91%
EBIT
9.71B8.26B5.96B4.55B5.30B5.38B4.58B2.75B2.56B3.25B1.93B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Lam Research's income statement

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.